A randomised trial of the effects of SGLT2 inhibition versus metformin on decline in renal function when used as first line therapy in type 2 diabetes

  • Neal, Bruce Charles (Primary Chief Investigator (PCI))
  • Arnott, Clare (Chief Investigator (CI))
  • Perkovic, Vlado (Chief Investigator (CI))
  • Zoungas, Sophia (Chief Investigator (CI))
  • Lambers Heerspink, Hiddo (Chief Investigator (CI))
  • Usherwood, Tim P. (Chief Investigator (CI))
  • Di Tanna, Gian Luca (Chief Investigator (CI))
  • Monaghan, Helen (Chief Investigator (CI))
  • Lung, Thomas (Chief Investigator (CI))

Project: Research

Project Details

StatusActive
Effective start/end date1/01/21 → 30/06/25